Table Of Contents:

1. Market Context & Strategic Relevance

 1.1 Opening Context (Why the market matters)

  1.1.1 Why This Market Is Gaining Strategic Attention

  1.1.2 Business Decisions This Report Supports

 1.2 Scope

 1.3 Research & Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Type

  2.3.2 Market Size By Isotope

  2.3.3 Market Size By Application

  2.3.4 Market Size By End User

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Isotope Producers (Reactors, Cyclotrons & Generators)

  3.4.2 Radiopharmaceutical Manufacturers & Radiolabeling Providers

  3.4.3 Radiopharmacies, Distributors & Logistics Providers

  3.4.4 Hospitals, Imaging Centers & Research Institutes

 3.5 Industry Life Cycle Assessment

4. Statistical Insights & Trends Reporting

 4.1 Disease Burden & Clinical Demand Indicators

  4.1.1 Cancer Incidence by Type (Prostate & Neuroendocrine)

  4.1.2 Nuclear Medicine Procedure Volumes

  4.1.3 PET & SPECT Imaging Procedure Trends

  4.1.4 Cardiovascular & Neurological Imaging Volumes

 4.2 Isotope Supply & Production Capacity

  4.2.1 Reactor-Based Isotope Production Capacity

  4.2.2 Cyclotron & Accelerator Installed Base

  4.2.3 Molybdenum-99 & Technetium-99m Supply Reliability

  4.2.4 Lutetium-177 & Actinium-225 Supply Expansion

 4.3 Clinical Pipeline & Regulatory Environment

  4.3.1 Radioligand Therapy Clinical Trial Activity

  4.3.2 Radiopharmaceutical Regulatory Approvals

  4.3.3 Radiation Safety & Handling Regulations

  4.3.4 Reimbursement Policies for Nuclear Medicine

 4.4 Manufacturing, Logistics & Delivery Metrics

  4.4.1 Short Half-Life Delivery Time Requirements

  4.4.2 Radiopharmacy Network Density

  4.4.3 Radioligand Manufacturing Site Expansion

  4.4.4 Transport & Cold Handling Requirements

 4.5 Technology & Adoption Trends

  4.5.1 Theranostics Adoption

  4.5.2 PSMA & Somatostatin Receptor Targeted Therapy Uptake

  4.5.3 Automated Radiosynthesis Module Deployment

  4.5.4 Alpha-Emitter Therapy Development

5. Radiopharmaceuticals Market Segmental Analysis & Forecast, By Type, 2022–2035, Value (USD Billion)

 5.1 Introduction

 5.2 Diagnostic Radiopharmaceuticals

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022–2035

 5.3 Therapeutic Radiopharmaceuticals

6. Radiopharmaceuticals Market Segmental Analysis & Forecast, By Isotope, 2022–2035, Value (USD Billion)

 6.1 Introduction

 6.2 Technetium-99m

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

 6.3 Fluorine-18

 6.4 Gallium-68

 6.5 Lutetium-177

 6.6 Iodine-131

 6.7 Other Isotopes

7. Radiopharmaceuticals Market Segmental Analysis & Forecast, By Application, 2022–2035, Value (USD Billion)

 7.1 Introduction

 7.2 Oncology

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

 7.3 Cardiology

 7.4 Neurology

 7.5 Other Applications

8. Radiopharmaceuticals Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)

 8.1 Introduction

 8.2 Hospitals and Clinics

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022–2035

 8.3 Diagnostic Imaging Centers

 8.4 Academic and Research Institutes

9. Radiopharmaceuticals Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

 9.1 Introduction

 9.2 North America

  9.2.1 Key Trends

  9.2.2 Radiopharmaceuticals Market Size & Forecast, By Type, 2022–2035

  9.2.3 Radiopharmaceuticals Market Size & Forecast, By Isotope, 2022–2035

  9.2.4 Radiopharmaceuticals Market Size & Forecast, By Application, 2022–2035

  9.2.5 Radiopharmaceuticals Market Size & Forecast, By End User, 2022–2035

  9.2.6 Radiopharmaceuticals Market Size & Forecast, By Country, 2022–2035

   9.2.6.1 USA

   9.2.6.2 Canada

 9.3 Europe

  9.3.1 Key Trends

  9.3.2 Radiopharmaceuticals Market Size & Forecast, By Type, 2022–2035

  9.3.3 Radiopharmaceuticals Market Size & Forecast, By Isotope, 2022–2035

  9.3.4 Radiopharmaceuticals Market Size & Forecast, By Application, 2022–2035

  9.3.5 Radiopharmaceuticals Market Size & Forecast, By End User, 2022–2035

  9.3.6 Radiopharmaceuticals Market Size & Forecast, By Country, 2022–2035

   9.3.6.1 Germany

   9.3.6.2 UK

   9.3.6.3 France

   9.3.6.4 Italy

   9.3.6.5 Spain

   9.3.6.6 Russia

   9.3.6.7 Poland

   9.3.6.8 Rest of Europe

 9.4 Asia-Pacific

  9.4.1 Key Trends

  9.4.2 Radiopharmaceuticals Market Size & Forecast, By Type, 2022–2035

  9.4.3 Radiopharmaceuticals Market Size & Forecast, By Isotope, 2022–2035

  9.4.4 Radiopharmaceuticals Market Size & Forecast, By Application, 2022–2035

  9.4.5 Radiopharmaceuticals Market Size & Forecast, By End User, 2022–2035

  9.4.6 Radiopharmaceuticals Market Size & Forecast, By Country, 2022–2035

   9.4.6.1 China

   9.4.6.2 India

   9.4.6.3 Japan

   9.4.6.4 South Korea

   9.4.6.5 Australia

   9.4.6.6 ASEAN Countries

   9.4.6.7 Rest of Asia-Pacific

 9.5 Latin America

  9.5.1 Key Trends

  9.5.2 Radiopharmaceuticals Market Size & Forecast, By Type, 2022–2035

  9.5.3 Radiopharmaceuticals Market Size & Forecast, By Isotope, 2022–2035

  9.5.4 Radiopharmaceuticals Market Size & Forecast, By Application, 2022–2035

  9.5.5 Radiopharmaceuticals Market Size & Forecast, By End User, 2022–2035

  9.5.6 Radiopharmaceuticals Market Size & Forecast, By Country, 2022–2035

   9.5.6.1 Brazil

   9.5.6.2 Argentina

   9.5.6.3 Mexico

   9.5.6.4 Colombia

   9.5.6.5 Rest of Latin America

 9.6 Middle East & Africa

  9.6.1 Key Trends

  9.6.2 Radiopharmaceuticals Market Size & Forecast, By Type, 2022–2035

  9.6.3 Radiopharmaceuticals Market Size & Forecast, By Isotope, 2022–2035

  9.6.4 Radiopharmaceuticals Market Size & Forecast, By Application, 2022–2035

  9.6.5 Radiopharmaceuticals Market Size & Forecast, By End User, 2022–2035

  9.6.6 Radiopharmaceuticals Market Size & Forecast, By Country, 2022–2035

   9.6.6.1 UAE

   9.6.6.2 Saudi Arabia

   9.6.6.3 Qatar

   9.6.6.4 South Africa

   9.6.6.5 Rest of Middle East & Africa

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Year-Wise Strategies & Development, 2022–2026

 10.3 Market Share Analysis, 2025

 10.4 Product/Service & Application Benchmarking

  10.4.1 Product/Service Specifications & Features By Key Players

  10.4.2 Product/Service Heatmap By Key Players

  10.4.3 Application Heatmap By Key Players

 10.5 Industry Start-Up & Innovation Landscape

 10.6 Key Company Profiles

  10.6.1 Novartis AG (Advanced Accelerator Applications)

   10.6.1.1 Company Overview & Snapshot

   10.6.1.2 Product/Service Portfolio

   10.6.1.3 Key Company Financials

   10.6.1.4 Geographical Presence

   10.6.1.5 SWOT Analysis

  10.6.2 Lantheus Holdings, Inc.

  10.6.3 Curium

  10.6.4 Telix Pharmaceuticals Limited

  10.6.5 GE HealthCare Technologies Inc.

  10.6.6 Cardinal Health, Inc.

  10.6.7 Jubilant Radiopharma

  10.6.8 Eckert & Ziegler SE

  10.6.9 ITM Isotope Technologies Munich SE

  10.6.10 Orano Med

  10.6.11 NorthStar Medical Radioisotopes, LLC

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions On Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List Of Tables

 14.2 List Of Figures